[
  {
    "NCT ID": "NCT02587312",
    "Brief Title": "Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers",
    "Official Title": "Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2016-10-13T00:00:00",
    "Completion Date": "2019-08-31T00:00:00",
    "Primary Completion Date": "2019-08-28T00:00:00",
    "Conditions Treated": "Nicotine Dependence",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Brown University",
    "All Sponsors": "Brown University",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT00088881",
    "Brief Title": "Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma",
    "Official Title": "A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients With Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "TERMINATED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2004-12-01T00:00:00",
    "Completion Date": "2011-03-01T00:00:00",
    "Primary Completion Date": "2011-03-01T00:00:00",
    "Conditions Treated": "Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "National Cancer Institute (NCI)",
    "All Sponsors": "National Cancer Institute (NCI)",
    "Sponsor Types": "NIH",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": true,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT06956781",
    "Brief Title": "Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)",
    "Official Title": "Optimizing Behavioral Health Services Following Pediatric Trauma Exposure",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "NOT_YET_RECRUITING",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2025-09-01T00:00:00",
    "Completion Date": "2028-08-01T00:00:00",
    "Primary Completion Date": "2028-08-01T00:00:00",
    "Conditions Treated": "PTSD; Trauma; Pediatric ALL",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "University of Rochester",
    "All Sponsors": "University of Rochester",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": true,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT01854112",
    "Brief Title": "Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma",
    "Official Title": "",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "UNKNOWN",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2012-11-01T00:00:00",
    "Completion Date": null,
    "Primary Completion Date": "2017-12-01T00:00:00",
    "Conditions Treated": "T-cell Lymphoma",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Far Eastern Memorial Hospital",
    "All Sponsors": "Far Eastern Memorial Hospital",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT00075881",
    "Brief Title": "Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma",
    "Official Title": "Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "PHASE2",
    "Phase Details": "Phase 2 (Efficacy)",
    "Start Date": "2004-01-01T00:00:00",
    "Completion Date": "2012-10-01T00:00:00",
    "Primary Completion Date": "2012-10-01T00:00:00",
    "Conditions Treated": "Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "National Cancer Institute (NCI)",
    "All Sponsors": "National Cancer Institute (NCI)",
    "Sponsor Types": "NIH",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": true,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT03729765",
    "Brief Title": "Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients",
    "Official Title": "A Randomized, Controlled Trial: Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "RECRUITING",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2018-10-19T00:00:00",
    "Completion Date": "2023-12-31T00:00:00",
    "Primary Completion Date": "2022-01-31T00:00:00",
    "Conditions Treated": "Cardiogenic Shock",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Beijing Anzhen Hospital",
    "All Sponsors": "Beijing Anzhen Hospital",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": true,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT02490319",
    "Brief Title": "Study on the Biological Prediction Models of Radiation Pneumonitis",
    "Official Title": "Study on the Biological Prediction Models of Radiation Pneumonitis",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "UNKNOWN",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2008-09-01T00:00:00",
    "Completion Date": null,
    "Primary Completion Date": "2023-07-01T00:00:00",
    "Conditions Treated": "Radiation Pneumonitis",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Huazhong University of Science and Technology",
    "All Sponsors": "Huazhong University of Science and Technology",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT01292330",
    "Brief Title": "A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support",
    "Official Title": "A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "UNKNOWN",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2010-01-01T00:00:00",
    "Completion Date": "2011-11-01T00:00:00",
    "Primary Completion Date": "2011-09-01T00:00:00",
    "Conditions Treated": "Liver Cancer",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Peking Union Medical College Hospital",
    "All Sponsors": "Peking Union Medical College Hospital",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": false,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT05187130",
    "Brief Title": "The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer Patients",
    "Official Title": "The Effect of Mindfulnes Program on Stress, Depression and Psychological Well-being in Cancer Patients: Single Blinded Randomized Controlled Study",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": "NA",
    "Phase Details": "NA",
    "Start Date": "2021-07-20T00:00:00",
    "Completion Date": "2021-12-22T00:00:00",
    "Primary Completion Date": "2021-12-22T00:00:00",
    "Conditions Treated": "Neoplasms; Cancer",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Istanbul Aydın University",
    "All Sponsors": "Istanbul Aydın University",
    "Sponsor Types": "OTHER",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  },
  {
    "NCT ID": "NCT04811365",
    "Brief Title": "(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation",
    "Official Title": "Study Evaluating the Prevalence of the KIT D816V Mutation in Peripheral Blood of Patients With Evidence of Systemic Mast Cell Activation (MCA)",
    "Study Type": "INTERVENTIONAL",
    "Recruitment Status": "COMPLETED",
    "Current Phase": null,
    "Phase Details": "Not specified",
    "Start Date": "2021-06-29T00:00:00",
    "Completion Date": "2023-03-31T00:00:00",
    "Primary Completion Date": "2023-03-31T00:00:00",
    "Conditions Treated": "Systemic Mast Cell Activation; KIT D816V Mutation",
    "Interventions": "",
    "Intervention Types": "",
    "Intervention Names": "",
    "Lead Sponsor": "Blueprint Medicines Corporation",
    "All Sponsors": "Blueprint Medicines Corporation",
    "Sponsor Types": "INDUSTRY",
    "Study Locations": "",
    "Countries": "",
    "Cities": "",
    "Enrollment": null,
    "Study Population": null,
    "Is Interventional": true,
    "Has Drug Intervention": false,
    "Has Device Intervention": false,
    "Has Procedure Intervention": false,
    "Has Behavioral Intervention": false,
    "Has Biological Intervention": false,
    "Has Radiation Intervention": false,
    "Is Phase 0": false,
    "Is Phase 1": false,
    "Is Phase 2": false,
    "Is Phase 3": false,
    "Is Phase 4": false,
    "Is Recruiting": false,
    "Is Completed": true,
    "Is Terminated": false,
    "Is Suspended": false,
    "Is Not Yet Recruiting": false,
    "Is Active Not Recruiting": false
  }
]